|GH||GUARDANT HEALTH INC||1.95%|
|TRIL||TRILLIUM THERAPEUTICS INC NPV||1.93%|
|FATE||FATE THERAPEUTICS INC||1.92%|
|TDOC||TELADOC HEALTH INC||1.85%|
|ARGX||ARGENX SE ADR||1.81%|
|GMAB||GENMAB A/S DKK||1.81%|
|IOVA||IOVANCE BIOTHERAPEUTICS INC||1.80%|
|ALGN||ALIGN TECHNOLOGY INC||1.78%|
|EXAS||EXACT SCIENCES CORP||1.76%|
|LLY||ELI LILLY CORP||1.74%|
|XRAY||DENTSPLY SIRONA INC||1.73%|
|MRTX||MIRATI THERAPEUTICS INC||1.71%|
|ARNA||ARENA PHARMACEUTICALS INC||1.71%|
|IDXX||IDEXX LABS CORP||1.70%|
|CRL||CHARLES RIVER LABORATORIES INT INC||1.69%|
|NBIX||NEUROCRINE BIOSCIENCES INC||1.69%|
|NSTG||NANOSTRING TECHNOLOGIES INC||1.68%|
|ADPT||ADAPTIVE BIOTECHNOLOGIES CORPORATION||1.68%|
|SRPT||SAREPTA THERAPEUTICS INC||1.68%|
|MRK||MERCK & CO. NEW||1.67%|
|IQV||IQVIA HOLDINGS INC||1.67%|
|KRTX||KARUNA THERAPEUTICS, INC.||1.66%|
|SAGE||SAGE THERAPEUTICS INC||1.66%|
|ADUS||ADDUS HOMECARE CORPORATION||1.65%|
|HZNP||HORIZON THERAPEUTICS PLC||1.65%|
|GILD||GILEAD SCIENCES INC||1.65%|
|ACHC||ACADIA HEALTHCARE CO INC||1.64%|
|HRC||HILL-ROM HOLDINGS INC||1.63%|
|BMY||BRISTOL MYERS SQUIBB CO||1.62%|
|TPTX||TURNING PT THERAPEUTICS||1.61%|
|RVNC||REVANCE THERAPEUTICS INC||1.57%|
|ZBH||ZIMMER BIOMET HOLDINGS INC||1.56%|
|LH||LABORATORY CORP OF AMERICA||1.56%|
|KURA||KURA ONCOLOGY INC||1.55%|
|JAZZ||JAZZ PHARMACEUTICALS PLC||1.55%|
|UNH||UNITEDHEALTH GROUP INC||1.55%|
|CTLT||CATALENT INC USD 0.01||1.55%|
|MOH||MOLINA HEALTHCARE INC||1.47%|
|MTD||METTLER-TOLEDO INTERNATIONAL INC||1.18%|
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, GS GAMMA Advisors, LLC, and Guggenheim Partners India Management. Securities offered through Guggenheim Funds Distributors, LLC.
© 2020 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.